Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy.
Christiano R R AlvesRen ZhangAlec J JohnstoneReid GarnerPann H NweJennifer J SiranosianKathryn J SwobodaPublished in: Neurology (2019)
These findings indicate that decreased Crn levels reflect disease severity, suggesting that Crn is a candidate biomarker for SMA progression. We conclude that Crn measurements should be included in the routine analysis of all patients with SMA. In future studies, it will be important to determine whether Crn levels respond to molecular and gene therapies.